The Saliva Testing Gap in Hormone Therapy: Clinical Outcomes & Solutions

The DUTCH Podcast

The DUTCH Podcast
The Saliva Testing Gap in Hormone Therapy: Clinical Outcomes & Solutions
May 26, 2026 Episode 155
DUTCH Test

Send us Fan Mail

In this episode, Dr. Mark Holthouse joins Dr. Jaclyn Smeaton and DUTCH founder Mark Newman to discuss a recent peer-reviewed publication from Precision Analytical, Inc. in Frontiers on hormone monitoring methods, including saliva testing, for testosterone hormone therapy. 

Their discussion also covers: 

  • How saliva values spike when measuring transdermal testosterone or estradiol and the clinical impact 
  • Dosing using saliva values and how it can cause overdosing or underdosing 
  • The complexity of estradiol monitoring 
  • The importance of relying on clinical evidence over established practice 
  • Serum and urine testing’s clinical validity and how test values align with clinical outcomes 

Show Notes 

Read our DUTCH Article on the Frontiers study, Mark Newman’s commentary, and the full study here

Check out the resources mentioned in this episode: 

Become a DUTCH Provider to gain access to comprehensive patient reports, peer-reviewed and validated research, and expert clinical support.